Detecting early treatment failure in stage IV colon cancer
Part of Cancer, Digestive system clinical trials.
This study looks for early signs that treatment is not working in people with stage IV colon or rectal cancer that has spread only to the liver. It may help doctors adjust care sooner by using regular blood, stool, and tissue samples around liver procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and can consent for yourself (male or female).
- You have stage IV colon or rectal cancer with liver-only spread, and a liver procedure is planned to try to cure (partial liver surgery or needle ablation).
- Your treatment plan is set up for pre-surgery or during-procedure research samples (blood, stool, and tissue; sometimes several biopsy samples if there’s a single liver spot).
- You can provide serial (repeated) blood samples and stool/tissue samples for research throughout the care plan.
- You are willing to join the Exactis personalized treatment registry and follow the study’s sample schedule.
- You do not have other active cancers at the same time (besides your colon/rectal cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a tiny device that is placed in your liver tumor during surgery. It checks how well different chemotherapy drugs work on your specific cancer, which may help your doctor choose the best treatment for you.
This study looks for blood/tumor signals (“biomarkers”) that may help predict outcomes in people whose colorectal cancer returns and spreads after surgery. It mainly helps researchers understand who may do better or worse, which can guide future care.
This trial is for people with colorectal cancer that has spread to the liver. It tests whether adding a new drug (sotevtamab) to standard chemotherapy (FOLFOX) before surgery can help shrink tumors and improve outcomes.
This trial uses a blood test (MRD) to monitor for cancer return after surgery in patients with stage IV colorectal cancer that can be removed. The goal is to catch any recurrence early and guide further treatment.
This Phase 3 trial tests different ways to deliver chemotherapy for colon cancer that has spread only to the liver (with limited possible tiny lung spots). It looks at whether the treatment plan improves outcomes compared with another chemotherapy approach, using oxaliplatin and LV5FU2 (with or without irinotecan) plus an added targeted medicine.
This Phase 3 trial tests a treatment approach for colorectal cancer that cannot be removed with surgery at first but has spread only to the liver. It is intended for people whose tumor is RAS/BRAF “wild-type” and who are well enough to do daily activities, to see if the treatment can control the cancer better.
Hear when a new Colorectal Cancer Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.